174 related articles for article (PubMed ID: 7036909)
1. Bullous pemphigoid and antinuclear antibodies. Unmasking of basement membrane fluorescence in sodium chloride-treated substrates.
Danno K; Okamoto H; Miyauchi H; Imamura S
Arch Dermatol; 1982 Jan; 118(1):37-9. PubMed ID: 7036909
[TBL] [Abstract][Full Text] [Related]
2. Use of sodium-chloride separated human skin in detection of circulating anti-basement membrane zone antibodies.
Rasmussen HB; Brandrup F; Andersen J; Hagdrup H
Acta Derm Venereol; 1989; 69(6):515-9. PubMed ID: 2575326
[TBL] [Abstract][Full Text] [Related]
3. The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid.
Kelly SE; Wojnarowska F
Br J Dermatol; 1988 Jan; 118(1):31-40. PubMed ID: 3277659
[TBL] [Abstract][Full Text] [Related]
4. The predominance of IgG4 in prodromal bullous pemphigoid.
Lamb PM; Patton T; Deng JS
Int J Dermatol; 2008 Feb; 47(2):150-3. PubMed ID: 18211485
[TBL] [Abstract][Full Text] [Related]
5. Bullous pemphigoid: a correlative study of autoantibodies, circulating immune complexes and dermo-epidermal deposits.
Gomes MA; Dambuyant C; Thivolet J; Bussy R
Br J Dermatol; 1982 Jul; 107(1):43-51. PubMed ID: 6809029
[TBL] [Abstract][Full Text] [Related]
6. Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin.
Domloge-Hultsch N; Bisalbutra P; Gammon WR; Yancey KB
J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):946-51. PubMed ID: 1869682
[TBL] [Abstract][Full Text] [Related]
7. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
[TBL] [Abstract][Full Text] [Related]
8. The complement fixing ability of anti-basement membrane zone IgG subclass of herpes gestationis and bullous pemphigoid.
Suzuki M; Watanabe C; Yaoita H
Acta Derm Venereol; 1989; 69(1):6-11. PubMed ID: 2563610
[TBL] [Abstract][Full Text] [Related]
9. Vesicular pemphigoid--ultrastructural and immunoelectron microscopic study.
Hayakawa K; Shimizu H; Amagai M; Harada T; Nishikawa T; Yamasaki Y
Dermatologica; 1989; 178(4):213-6. PubMed ID: 2670619
[TBL] [Abstract][Full Text] [Related]
10. Absence of specific histologic changes in guinea pig skin treated with bullous pemphigoid antibodies.
Gammon WR; Briggaman RA
J Invest Dermatol; 1988 Apr; 90(4):495-500. PubMed ID: 3280699
[TBL] [Abstract][Full Text] [Related]
11. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
Brooks WS; Lee YY; Abell E; Deng JS
J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
[TBL] [Abstract][Full Text] [Related]
12. Correlation of serum anti-basement membrane zone antibody and malignancy in bullous pemphigoid.
Ahmed AR; Amerian ML
Dermatologica; 1985; 171(2):82-5. PubMed ID: 3899759
[TBL] [Abstract][Full Text] [Related]
13. Clinical, histological and immunological studies in 50 patients with bullous pemphigoid.
Hadi SM; Barnetson RS; Gawkrodger DJ; Saxena U; Bird P; Merrett TG
Dermatologica; 1988; 176(1):6-17. PubMed ID: 3276569
[TBL] [Abstract][Full Text] [Related]
14. Linear immunofluorescence staining of the cutaneous basement membrane zone produced by pemphigoid antibodies: the result of hemidesmosome staining.
Mutasim DF; Anhalt GJ; Diaz LA; Patel HP
J Am Acad Dermatol; 1987 Jan; 16(1 Pt 1):75-82. PubMed ID: 2433316
[TBL] [Abstract][Full Text] [Related]
15. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations.
Lazarova Z; Yancey KB
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276
[TBL] [Abstract][Full Text] [Related]
16. Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid.
Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo JR
J Invest Dermatol; 1982 Jan; 78(1):52-7. PubMed ID: 7033396
[TBL] [Abstract][Full Text] [Related]
17. Deposition of the membrane attack complex of complement in bullous pemphigoid.
Dahl MV; Falk RJ; Carpenter R; Michael AF
J Invest Dermatol; 1984 Feb; 82(2):132-5. PubMed ID: 6363566
[TBL] [Abstract][Full Text] [Related]
18. A comparative immunoelectron microscopic study of typical and atypical cases of pemphigoid.
Shimizu H; Hayakawa K; Nishikawa T
Br J Dermatol; 1988 Dec; 119(6):717-22. PubMed ID: 3060192
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural localization of in vitro binding sites of circulating anti-basement membrane zone antibodies in bullous pemphigoid.
Yamasaki Y; Nishikawa T
Acta Derm Venereol; 1983; 63(6):501-6. PubMed ID: 6198839
[TBL] [Abstract][Full Text] [Related]
20. Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy.
Ahmed AR; Maize JC; Provost TT
Arch Dermatol; 1977 Aug; 113(8):1043-6. PubMed ID: 329769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
